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2-Deoxyglucose Inhibits Induction of Chemokine Expression
in 3T3-L1 Adipocytes and Adipose Tissue Explants
Ryan W. Grant1, Jacqueline I. Boudreaux1, and Jacqueline M. Stephens2,3

Objective: To determine the influence of glycolytic inhibition on the adipocyte inflammatory response.
Methods: To determine the effect of 2-deoxyglucose (2-DOG) on the inflammatory response, mature
3T3-L1 adipocytes were co-treated with 2-DOG and LPS or TNF. To determine the effect of endoplasmic
reticulum stress on TNF-induced induction of chemokines, adipocytes were pretreated with thapsigargin
or salubrinal. Chemokine mRNA levels were determined using quantitative real-time PCR, and secretion
of CCL2 was determined by Western blot.
Results: 2-DOG treatment reduced the ability of LPS and TNF to induce CCL2 mRNA levels and reduced
secreted CCL2 protein levels in a dose-dependent manner. A similar pattern of mRNA regulation was
observed for other chemokines. The attenuation of TNF-induced CCL2 mRNA levels occurred regardless
of whether glucose or pyruvate was present in the media, suggesting that mechanisms other than glycolysis might mediate the observed effects. Treatment with the endoplasmic reticulum stressor thapsigargin
and the endoplasmic reticulum signaling activator salubrinal reduced chemokine mRNA levels similarly to
2-DOG.
Conclusions: Collectively, our data indicate that 2-DOG suppresses inflammatory chemokine induction in
adipocytes. The effects of 2-DOG do not seem to be linked to glycolysis but correlate with endoplasmic
reticulum stress activation.
Obesity (2017) 25, 76-84. doi:10.1002/oby.21668

Introduction
Obesity is characterized by a substantial increase in adipose tissueassociated immune cells that contribute to systemic inflammation.
For a 100 kg person with 50% body fat, this represents approximately 64 3 109 cells, which make up a large immunologically
active organ (1). Recruitment of immune cells is a key component
of the inflammatory response and is controlled by the secretion of
recruitment signals (e.g., chemokines) from various tissues. Adipocytes are the most abundant cell type in adipose tissue and are capable of secreting numerous chemokines that are elevated during
obesity.

metabolites, particularly succinate, that link glycolysis to LPSinduced expression of several inflammatory gene transcripts such as
IL-1b (2). Interestingly, the anti-inflammatory properties of 2-DOG
appear to be shared across immune cells, since 2-DOG treatment
has been shown to inhibit the development of TH17 cells while promoting the generation of Treg cells (4). Although studies using 2DOG have demonstrated that it has potent effects on inflammation,
the precise mechanisms that couple glycolytic inhibition to gene
expression remain unknown. There is also evidence that 2-DOG
influences glycosylation and has the ability to activate NF-jB, albeit
in a longer time frame (3 h) than immunological stimuli (5).

A growing literature suggests that macronutrient metabolism and
metabolic pathways control inflammatory responses. Recent findings
have suggested that M1 polarized macrophages rely on glycolysis
(2), while M2 macrophages rely on fatty acid oxidation (3). In addition, 2-deoxyglucose (2-DOG) is a glucose analog that functions as
a glycolytic inhibitor and is known to have anti-inflammatory properties (2). In macrophages, 2-DOG modulates intracellular

Evidence suggests that glucose metabolism controls the metabolic
response of adipocytes to inflammatory stimuli. Adipocyte lipolysis
is responsive to glucose concentrations, with higher glucose concentrations promoting lipolysis and glucose analogs inhibiting lipolysis
(6). These data suggest that glucose influences the metabolic
response to TNF and other inflammatory mediators in adipocytes.
However, the ability of glucose and glycolytic inhibitors to control
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the inflammatory response in adipocytes is not known. Because adipocytes secrete a wide variety of chemokines that control immune
cell recruitment, we sought to determine the role of glycolytic inhibition on chemokine mRNA levels and secretion in adipocytes challenged with inflammatory stimuli.

Methods
Cell culture
Murine 3T3-L1 preadipocytes, obtained from Dr. Green’s laboratory
(7), were grown, maintained, and induced to differentiate using a
standard protocol (8). Fully differentiated adipocytes were maintained in DMEM (Sigma-Aldrich, St Louis, MO) supplemented with
10% FBS (Sigma-Aldrich) until 2 days before experimentation when
cells were fed with 10% calf serum (Sigma-Aldrich). Prior to treatments, media was changed to low-glucose (5.5 mM) DMEM
(Sigma-Aldrich) and 1% calf serum overnight. For 20-h treatments,
cells were treated with 2-DOG and LPS or TNF concurrently. For
shorter treatments, cells were pretreated with 2-DOG (SigmaAldrich), thapsigargin (Sigma-Aldrich), or salubrinal (R&D Systems,
Minneapolis, MN) for 30 min and then treated with TNF (R&D Systems) for 1 to 4 h.

siRNA-mediated GLUT1 knockdown
Knockdown of GLUT1 was accomplished using a lipid-based transfection system (Dharmafect, GE Dharmacon, Lafayette, CO) and
performed as described previously (9). Briefly, 3T3-L1 adipocytes
were differentiated, and 7 to 10 days after differentiation, cells were
trypsinized and plated into 24-well plates using low-glucose DMEM
and 10% FBS. After replating, cells were treated with siRNA for
48 h and then challenged with 0.5 nM TNF. After 4 h of treatment,
cells were collected and analyzed for mRNA levels.

synthesized (High Capacity cDNA Reverse Transcription Kit,
Applied Biosystems, Foster City, CA), then real-time PCR was performed with the QuantStudio 7 Flex Real-Time PCR System
(Applied Biosystems). RNA was analyzed using a mouse chemokine
and receptors pathway array (SAB Biosciences, Valencia, CA), and
primer sets for CCL2 (F: GCAGAGAGCCAGACGGGAGGA, R:
TGGGGCGTTAACTGCATCTGG), CCL5 (F: GGGTACCATG
AAGATCTCTGC, R:TCTAGGGAGAGGTAGGCAAAG), CCL8
(F: AGGGATTGAGAGGACGTAG, R: GGTGACTGGAGCCTTAT
CTG), CXCL10 (F: TCAGCACCATGAACCCAA, R:CTATGGCC
CTCATTCTCACTG), and adiponectin (F: AAAAGGGCTCAGGA
TGCTACTG, R: TGGGCAGGATTAAGAGGAACA) were also
used to measure mRNA transcript levels. PPIA was used as the
housekeeping gene (all primers from Integrated DNA Technologies,
Coralville, IA). Samples were run in triplicate.

Western blotting
Protein concentration was measured using BCA protein assay
(Thermo ScientificTM PierceTM Protein Biology, Waltham, MA).
Proteins were separated in 10% polyacrylamide gels containing SDS
and transferred to nitrocellulose membrane (Bio-Rad, Hercules, CA)
in 25 mmol/L Tris, 192 mmol/L glycine, and 20% methanol. Nitrocellulose was blocked in casein blocking buffer (LI-COR Biosciences, Lincoln, NE) for 1 h and incubated with primary antibody overnight. A secondary anti-rabbit antibody (LI-COR) labeled with an
infrared label that emits signal at a wavelength of 680 nm was used.
Results were visualized and captured on an Odyssey CLx (LI-COR).

Statistical analysis
SAS statistical software (SAS Institute, Cary, NC) was used for all
statistical analyses. Cell culture experiments were analyzed using ttests. Adipose tissue explants were analyzed using a 2 3 2 factorial
design for the effects of 2-DOG and TNF. Results were considered
significantly different at P < 0.05

Animals and adipose tissue explants
Ad libitum chow-fed (Teklad 2018S) C57BL/6 female mice 5 to 6.5
months of age were used for epididymal adipose tissue explant studies for proof of concept that 2-DOG can modify the TNF-induced
inflammatory response in whole adipose tissue. Mice were euthanized in the fed state by CO2 asphyxiation. Tissues were collected
into low-glucose DMEM with 1% FBS and penicillin/streptomycin
as described by Strissel et al. (10). Explants were pretreated for 30
min with 2.0 mM 2-DOG and then treated with 0.5 nM TNF (R&D
Systems). After 4 h of TNF treatment, explants were collected and
analyzed for mRNA levels. All experiments and animal use were
conducted in compliance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee at
Purdue University.

RNA extraction and qRT-PCR
Following treatment, cells were collected in 350 mL of RLT Buffer
(Qiagen, Germantown, MD) and frozen at 2808C. Cell suspensions
were thawed and RNA was isolated using the RNeasy Mini Kit
(Qiagen) according to manufacturer instructions. RNA was eluted
from the mini columns in 30 mL of nuclease-free water then
assessed for concentration and purity using the NanoDrop 2000
Spectrophotometer (Thermo Scientific, Waltham, MA). cDNA was
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Results
2-DOG inhibits LPS-induced CCL2 secretion in
mature adipocytes
The influence of glycolytic inhibitors on adipocyte chemokine gene
expression and secretion in response to proinflammatory stimuli is
not known. To determine the influence of glycolytic inhibition on
the response to proinflammatory stimuli, LPS-induced chemokine
mRNA levels were measured in 3T3-L1 adipocytes. Mature adipocytes were treated with LPS alone or in the presence of 1.0 mM or
2.0 mM 2-DOG for 20 h. These doses of 2-DOG have previously
been shown to reduce inflammatory gene expression in macrophages
(2). LPS-induced CCL2 secretion into the cell culture media was
inhibited by 2-DOG in a dose-dependent manner with the greatest
inhibition occurring at the highest 2-DOG concentration (270%,
P < 0.05, Figure 1A, B). Differences in CCL2 secretion were mirrored by dose-dependent decreases in CCL2 mRNA in adipocytes
treated with LPS and 2-DOG (293%, P < 0.05, Figure 1C). Based
on CCL2 secretion in response to LPS, preadipocytes were relatively
unresponsive to 2-DOG, while the inhibitory effect of 2-DOG on
CCL2 secretion was larger in mature adipocytes (Figure 1D). These
data indicate that 2-DOG reduces CCL2 mRNA levels and CCL2
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Figure 1 2-DOG decreases LPS-induced CCL2 mRNA and secreted protein in 3T3-L1 adipocytes. Fully differentiated 3T3-L1 adipocytes were maintained in
5.5 mM glucose media and co-treated with 20 ng/mL LPS and different concentrations of 2-DOG for 20 h. (A) Secreted CCL2 protein was analyzed by Western blot of cell culture media in control, LPS, and 1 mM and 2 mM 2-DOG with LPS co-treatment and (B) secreted CCL2 band density was quantified. (C)
CCL2 mRNA was analyzed in control, LPS, and 1 mM and 2 mM 2-DOG with LPS co-treatment. (D) Secreted CCL2 was measured by Western blot of cell
culture media from preadipocytes and differentiated adipocytes treated for 20 h with control, LPS, and LPS with 2-DOG (0.25-2.0 mM). Data are presented
as the mean 6 SEM from representative experiments performed independently three times.

secretion in response to LPS, and that modulation of mRNA may be
a critical target of 2-DOG in mature adipocytes.

2-DOG reduces TNF-induced CCL2 mRNA levels
in mature adipocytes
Although LPS is known to drive proinflammatory gene expression in
adipocytes, its role in driving adipocyte dysfunction during obesity and
its associated metabolic diseases is less established. Hence, we examined the actions of TNF, a well-established mediator of adipose tissue
inflammation and dysfunction during obesity and type 2 diabetes (11).
We tested the capacity of 2-DOG to regulate TNF-induced CCL2
mRNA levels. Mature adipocytes were treated with TNF, or co-treated
with TNF and 2-DOG (1.0 and 2.0 mM) for 20 h (Figure 2A). Similar
to the experiments using LPS described above, TNF significantly
increased CCL2 mRNA levels compared with control adipocytes.
TNF-induced CCL2 mRNA levels were decreased by co-treatment
with 2-DOG in a dose-dependent fashion with the greatest inhibition
occurring at 2.0 mM (283%, P < 0.01). We also used a targeted mouse
chemokine PCR array and observed that the mRNA levels of 10 chemokines were regulated in a similar fashion (Table 1). These data
clearly demonstrate that 2-DOG reduces the expression of several chemokines in 3T3-L1 adipocytes in response to TNF and LPS treatment.
We performed additional experiments to understand the time frame
in which 2-DOG is effective. Induction of CCL2 by TNF occurred
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after a 1-h treatment and increased over an 8-h treatment. However,
the most dramatic increases were observed after 1 and 2 h (Figure
2B). To determine the acute effects of 2-DOG, adipocytes were pretreated for 30 min with 2-DOG and then stimulated with TNF for
1 h. 2-DOG significantly reduced CCL2 mRNA levels (252%,
P < 0.05) at 1 h, indicating acute inhibitory effects of 2-DOG (Figure 2C). To further assess whether the effects of 2-DOG were reliant
on glycolysis, we used an experimental paradigm where the cell culture media contained either 10.0 mM glucose (substrate of glycolysis) or 10.0 mM pyruvate (end product of glycolysis). Surprisingly,
2-DOG was effective at reducing (P < 0.05) CCL2 mRNA levels in
either glucose or pyruvate containing media (Figure 2D). No differences were observed between cells in glucose or pyruvate containing
media in control and TNF-stimulated conditions.

GLUT1 knockdown modestly increases CCL2
mRNA
In adipose tissue, macrophage-derived TNF acts on adipocytes to
increase basal glucose transport and reduce insulin sensitivity (12).
GLUT1 is a basal glucose transporter whose expression is increased
in 3T3-L1 adipocytes by proinflammatory factors including TNF
(12). To determine if glucose transport via GLUT1 plays a role in
TNF-induced CCL2 mRNA, we knocked down the GLUT1 gene
using siRNA in mature adipocytes. Knockdown of GLUT1 protein
was successful (270%, Figure 3A, B). At 4 h of TNF treatment,

www.obesityjournal.org

Original Article

Obesity

OBESITY BIOLOGY AND INTEGRATED PHYSIOLOGY

Figure 2 2-DOG decreases TNF-induced CCL2 mRNA in 3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were maintained in
5.5 mM glucose media and were co-treated with 0.5 nM TNF and 1 or 2 mM 2-DOG. (A) CCL2 mRNA was measured in control,
TNF, and 1 and 2 mM 2-DOG with TNF co-treatment after 20 h. (B) Time course of CCL2 mRNA response to 0.5 nM TNF from 0 to
8 h. (C) CCL2 mRNA was measured after 30 min of pretreatment with 2-DOG and 1 h of treatment with 0.5 nM TNF in control, 2DOG, TNF, and 2-DOG followed by TNF. (D) The influence of media containing 10.0 mM glucose or 10.0 mM pyruvate on the suppressive effect of 2-DOG on TNF-induced CCL2 mRNA. Data are presented as the mean 6 SEM. Experiments on the acute effects
of 2-DOG were performed independently three times.

differences in CCL2 protein were not detected in cell extracts (Figure 3A, B); however, TNF-treated adipocytes had modestly
increased secretion of CCL2 compared with unstimulated cells, and
this was unaffected by GLUT1 knockdown (Figure 3C, D). CCL2
mRNA was modestly increased (P < 0.01) in adipocytes treated with

TNF and GLUT1 siRNA (Figure 3E). Although differences in
mRNA expression were detected, differences detected at the protein
level likely take longer than 4 h to develop because of the modest
difference in mRNA and the time necessary for transcription and
translation to occur. These results indicate that a reduction in

TABLE 1 2-DOG co-treatment reduces adipocyte chemokine mRNA levels

Fold change
Gene name
Chemokine
Chemokine
Chemokine
Chemokine
Chemokine
Chemokine
Chemokine
Chemokine
Chemokine

(C-C motif) ligand 2
(C-C motif) ligand 5
(C-C motif) ligand 7
(C-C motif) ligand 8
(C-C motif) ligand 9
(C-C motif) receptor
(C-X-C motif) ligand
(C-X-C motif) ligand
(C-X-C motif) ligand
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Gene symbol

like 2
5
9
10

Ccl2
Ccl5
Ccl7
Ccl8
Ccl9
Ccrl2
Cxcl5
Cxcl9
Cxcl10

TNF
2-DOG

2
2

1
2

1
1 mM

1
2 mM

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

196.99
274.98
72.39
9.66
12.77
29.16
39.50
75.78
58.47

107.51
47.41
56.28
2.86
4.88
4.04
12.43
11.45
14.06

60.40
33.70
33.69
1.69
2.88
2.14
6.96
10.91
10.20
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Figure 3 GLUT1 knockdown increases TNF-induced CCL2 mRNA in 3T3-L1 adipocytes. Mature 3T3-L1 adipocytes were transfected with GLUT1 siRNA 7-10
days after induction of differentiation. (A) Western blots of whole cell extracts analyzing GLUT1, CCL2, and b-actin from cells transfected with nontargeted
siRNA and treated with TNF (0.5 nM). (B) Quantification of GLUT1 and CCL2 protein band density relative to b-actin from panel A. (C) Western blot of
secreted CCL2 protein in the cell culture media was from cells treated with nontargeted or GLUT1 siRNA and vehicle or TNF. (D) Quantification of secreted
CCL2 band density of Figure 5C. (E) CCL2 mRNA was analyzed in control and TNF-treated cells in untransfected, nontargeted siRNA and GLUT1 siRNA
treated samples. Data are presented as the mean 6 SEM from representative experiments performed independently three times.

GLUT1 expression modestly increases TNF-induced gene expression
of CCL2 and does not protect 3T3-L1 adipocytes from TNFinduction of CCL2.

Pretreatment with thapsigargin or salubrinal
inhibits the induction of chemokines in response
to TNF
2-DOG was effective in reducing mRNA levels of inflammatory
genes even when the end product of glycolysis was provided, suggesting that its effects are likely mediated through nonglycolytic
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pathways. 2-DOG is also known to interfere with the formation of
glycoproteins by inhibiting the transfer of dolichol oligosaccharides
to glycoproteins and induces the unfolded protein response (UPR)
(13). To determine the influence of pretreatment with a UPR activator on TNF-induced chemokine expression mature 3T3-L1 adipocytes were pretreated with 1 lM thapsigargin for 30 min, and then
treated with 0.5 nM TNF for 4 h. TNF significantly increased
mRNA expression of CCL2, CCL5, CCL8, and CXCL10 (Figure
4A-D). However, pretreatment with thapsigargin blunted the TNF
response in a manner similar to 2mM 2-DOG (Figure 4A-D). These
data confirm mRNA alterations in genes identified by the targeted
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Figure 4 Thapsigargin decreases TNF-induced chemokine mRNA in 3T3-L1 adipocytes. Fully differentiated 3T3-L1 adipocytes
were maintained in 5.5 mM glucose media and were pretreated with thapsigargin (1.0 lM) and 2-DOG (2 mM) for 30 min and
then treated with 0.5 nM TNF for 4 h. (A) CCL2, (B) CCL5, (C) CCL8, and (D) CXCL10 mRNA was analyzed in control, TNF,
and thapsigarin/TNF or 2-DOG/TNF treatments. Data are presented as the mean 6 SEM from representative experiments performed independently three times.

chemokine array (Table 1) and also indicate that the effects of 2DOG on chemokine expression are similar to those induced by the
UPR activator thapsigargin. To further understand the contribution
of pathways downstream of the UPR, cells were pretreated with
either 2-DOG or salubrinal, which causes the accumulation of phosphorylated eIF2a by inhibiting its de-phosphorylation. Interestingly,
salubrinal dose-dependently decreased TNF-induced expression of
CCL2, CCL5, CCL8, and CXCL10 (Figure 5). These data indicate
that UPR activation and UPR signaling pathways have the capacity
to significantly regulate the secretion of chemokines in adipocytes.

2-DOG reduces chemokine mRNA levels in
adipose tissue explants
2-DOG effectively reduces LPS and TNF-induced chemokine
mRNA levels in 3T3-L1 adipocytes in vitro. Hence, we determined
whether 2-DOG would be effective in reducing TNF-induced chemokine levels in whole adipose tissue. Adipose tissue explants from

www.obesityjournal.org

female mice were pretreated with 2-DOG for 30 min and then
treated with TNF. 2-DOG alone reduced CCL2 mRNA levels
(224% P < 0.05, Figure 6A). This is likely because basal levels of
TNF and other proinflammatory cytokines maintain CCL2 gene
expression in adipose tissue. Our ex vivo analysis also showed that
TNF increased CCL2 mRNA levels and pretreatment with 2-DOG
reduced TNF-induced CCL2 mRNA to basal levels (228%,
P < 0.01, Figure 6A). These results are consistent with our experiments in 3T3-L1 adipocytes (Figure 2). Similarly, TNF-induced
CCL5 mRNA levels were reduced by pretreatment with 2-DOG in
ex vivo conditions (254%, P < 0.01, Figure 6B). Adiponectin
mRNA levels did not vary with 2-DOG or TNF treatment (Figure
6C). Adiponectin mRNA is very stable (14), and unlikely to change
due to the short TNF treatment time. These results indicate the 2DOG can act on whole adipose tissue to reduce chemokine mRNA
levels. These results should be interpreted with caution because
other cell types in adipose tissue are known to be targets of 2-DOG
and may be contributing to this ex vivo response.

Obesity | VOLUME 25 | NUMBER 1 | JANUARY 2017
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Figure 5 Salubrinal decreases TNF-induced chemokine mRNA in 3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were
maintained in 5.5 mM glucose media and were pretreated with salubrinal (0.0-8.0 lM) for 30 min and then treated with
0.5 nM TNF for 4 h. (A) CCL2, (B) CCL5, (C) CCL8, and (D) CXCL10 mRNA was analyzed in control, TNF, and salubrinal/TNF
treatments. Data are presented as the mean 6 SEM from representative experiments performed independently three times.

Discussion
Our novel observations reveal that 2-DOG inhibits TNF-induced
increases of chemokine mRNA in cultured adipocytes and adipose

tissue explants. Surprisingly, these results were not affected by
media glucose concentrations, and GLUT1 knockdown increased
CCL2 mRNA levels. These results indicate that the effects of 2DOG on TNF-induced mRNA levels in the adipocyte are likely not

Figure 6 2-DOG decreases TNF-induced CCL2 and CCL5 mRNA in adipose tissue explants. Gonadal explants from 5- to 6-month-old C57BL/6 female mice
(n 5 5) were pretreated with 2-DOG for 30 min, which was followed by treatment with 0.5 nM TNF for 4 h. Whole adipose tissue mRNA was analyzed for (A)
CCL2, (B) CCL5, and (C) adiponectin. Data are presented as the mean 6 SEM.
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related to glycolytic inhibition. Instead, the anti-inflammatory effects
of 2-DOG on adipocytes may be related to the activation of endoplasmic reticulum (ER) stress pathways and downstream signaling
events. Thus, 2-DOG not only influences metabolism, but also modulates other pathways that regulate the adipocyte inflammatory
response.
Glycolytic inhibition by 2-DOG has previously been linked with
improvements in metabolism and aging. Initial studies demonstrated
that 2-DOG can improve markers associated with caloric restriction
including improved blood glucose homeostasis, reduced heart rate,
and reduced blood pressure (15,16). Other studies have demonstrated
that 2-DOG impacts pathways associated with stress response, particularly in models of neuronal damage including iron (17),
amyloid-B-peptide
(17),
and
1-methyl-4-phenyl-1,2,3,5tetrahydropyridine (18). 2-DOG has been shown to induce GRP78
and HSP70 in many of these models (17,19,20). Initially the data on
2-DOG as a caloric restriction mimetic was positive. However,
long-term studies using 2-DOG demonstrate that it can cause heart
failure in multiple strains of rats (21). Interestingly, our results suggest that the effects of 2-DOG are not solely related to glycolysis,
but suggest that ER stress signaling pathways may contribute to the
effects of 2-DOG on inflammation and metabolism. Determining the
contribution of glycolysis versus ER stress signaling to the functions
of 2-DOG and their tissue specificity may yield important information on the biology of aging.
Activation of the UPR contributes to cellular homeostasis by regulating protein expression, stabilization and degradation; however,
prolonged UPR activation can lead to apoptosis. In this series of
experiments, acute activation was able to block the inflammatory
response to TNF; however, chronic stimulation may produce different effects. This study indicates that activation of the signaling factor eIF2a may be responsible for reductions chemokine mRNA by
ER stress. Recent work by others has demonstrated that overexpression of the ER signaling protein XBP-1 is sufficient to down regulate metabolic enzymes in a manner similar to TNF (22). Given that
multiple signaling pathways arising from the ER influence autophagy (23), future work will be needed to examine pathway specificity. However, the effects of salubrinal indicate that eIF2a phosphorylation is critical to UPR regulation of the inflammatory response.
The extent to which chemokine expression can modify obesityinduced adipose inflammation has been investigated primarily
through the use of global knockout mice. Targeting the production
of single chemokines has been problematic with some studies indicating strong protection of CCL22/2 mice from macrophage accumulation (24) and overexpression of CCL2 has been demonstrated
to drive adipose tissue macrophage accumulation (25). While other
studies demonstrate only modest protection from inflammation in
CCL2 knockouts fed a high-fat diet (26,27). CCR2, the receptor for
CCL2 and other MCP family chemokines, are protected against
insulin resistance (28,29). Designing approaches that target multiple
chemokines and their response to inflammatory stimuli may be a
way forward in this regard. 2-DOG and the pathways that it activates may be favorable in this respect because it targets multiple
chemokines.
Overall, our studies show that 2-DOG has the capacity to suppress
TNF-induced chemokine mRNA levels. Although the function of 2DOG is oftentimes attributed to its effects on glycolysis, our data
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strongly suggest the involvement of other cellular processes. Our
results suggest that 2-DOG can function to suppress induction of a
specific subset of chemokines and it may do this through the induction of ER stress in adipocytes. Future studies in this area will be
needed to determine the responsible signaling pathways and whether
they can be specifically targeted for reducing metabolic
inflammation.O
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